| 書目名稱 | Drugs between Research and Regulations |
| 副標(biāo)題 | Proceedings of the 5 |
| 編輯 | C. Steichele (Medizinischer Direktor),U. Abshagen |
| 視頻video | http://file.papertrans.cn/284/283216/283216.mp4 |
| 圖書封面 |  |
| 描述 | Franz Gross died suddenly during preparations for the meeting. He would have taken great pleasure in summarizing in this preface the aims and results of a gathering which so clearly bore his imprint as Chairman of the Scientific Program Committee. His sudden passing away is deeply regretted by all of us: organizers, speakers and participants. We greatly respect him for his exceptional abilities, his impact on science and his qualities as a human being. He provided the impulse for a well balanced and topical scientific program. We therefore dedicate the proceedings of this symposium to his memory. Munich was the fifth in a traditional line of international meetings of pharmaceutical physicians held at three-year intervals, starting in London in 1972 (‘International Aspects of Drug Evaluation and Usage‘), and followed by Florence in 1975 (,Rationality of Drug Development‘), Brussels in 1978 (,Pharmaceutical Medicine - the Future‘) and Paris in 1981 (‘Drug Safety -;- Progress and Controversies‘). This 5th meeting discussed improvements in drug development and application and examined the impact of regulatory activities. |
| 出版日期 | Conference proceedings 1985 |
| 關(guān)鍵詞 | Rauwolfia; cancer; clinical trial; drug; drug development; drug safety; lipide; research; toxicity |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-642-54130-8 |
| isbn_softcover | 978-3-642-54132-2 |
| isbn_ebook | 978-3-642-54130-8 |
| copyright | Springer-Verlag Berlin Heidelberg 1985 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-28 23:40
發(fā)表于 2025-3-21 17:33:23
